Shares of Moderna MRNA rose about 4% on Friday after the company announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorization to ...
Zacks Investment Research on MSN
Moderna stock jumps after FDA reverses course on flu shot
Shares of Moderna MRNA rose 6% on Wednesday after the company announced that the FDA agreed to review its regulatory filing seeking approval for its seasonal influenza vaccine, mRNA-1010. A final ...
Moderna (NASDAQ:MRNA) Stock, Option Chain Option chain shows key data for Moderna's stock options at various strike prices and expiration dates. Traders use this information to analyze potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results